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Chronic inflammation due to obesity contributes to
the development ofmetabolic diseases, autoimmune
diseases, and cancer. Reciprocal interactions be-
tween metabolic systems and immune cells have
pivotal roles in the pathogenesis of obesity-associ-
ated diseases, although the mechanisms regulating
obesity-associated inflammatory diseases are still
unclear. In the present study, we performed tran-
scriptional profiling of memory phenotype CD4
T cells in high-fat-fed mice and identified acetyl-
CoA carboxylase 1 (ACC1, the gene product of
Acaca) as an essential regulator of Th17 cell differen-
tiation in vitro and of the pathogenicity of Th17 cells
in vivo. ACC1 modulates the DNA binding of RORgt
to target genes in differentiating Th17 cells. In addi-
tion, we found a strong correlation between IL-17A-
producing CD45RO+CD4 T cells and the expression
of ACACA in obese subjects. Thus, ACC1 confers
the appropriate function of RORgt through fatty
acid synthesis and regulates the obesity-related
pathology of Th17 cells.
INTRODUCTION
The prevalence of obesity has been increasing worldwide, and
obesity is now a major public health problem in most developed
countries (Gregor and Hotamisligil, 2011; Ng et al., 2014).
Obesity-induced inflammation contributes to the development
of various chronic diseases, such as autoimmune diseases,
metabolic diseases, and cancer (Kanneganti and Dixit, 2012;
Kim et al., 2014; Osborn and Olefsky, 2012; Winer et al.,
2009a). A number of studies have pointed out the importance of
reciprocal interactions between metabolic systems and immune
cells in the pathogenesis of obesity-associated diseases (Kamin-
ski and Randall, 2010; Kanneganti and Dixit, 2012; Kim et al.,
2014;Mauer et al., 2014; Stienstra et al., 2012;Winer et al., 2011).1042 Cell Reports 12, 1042–1055, August 11, 2015 ª2015 The AuthoElucidating the molecular mechanisms by which naive CD4
T cells differentiate into effector T cells is crucial for understand-
ing helper T (Th) cell-mediated immune pathogenicity. After anti-
gen stimulation, naive CD4 T cells differentiate into at least four
distinct Th cell subsets: Th1, Th2, Th17, and inducible regulatory
T (iTreg) cells (O’Shea and Paul, 2010; Reiner, 2007). Several
specific master transcription factors that regulate Th1/Th2/
Th17/iTreg cell differentiation have been identified, including
T-bet for Th1 (Szabo et al., 2000), GATA3 (Yamashita et al.,
2004; Zheng and Flavell, 1997) for Th2, retinoic-acid-receptor-
related orphan receptor gt (RORgt) for Th17 (Ivanov et al.,
2006), and forkhead box protein 3 (Foxp3) for iTreg (Sakaguchi
et al., 2008). The appropriate expression and function of these
transcription factors is essential for proper immune regulation
by each Th cell subset.
Among these Th cell subsets, Th17 cells contribute to the host
defense against fungi and extracellular bacteria (Milner et al.,
2008). However, the pathogenicity of IL-17-producing T cells
has been recognized in various autoimmune diseases, including
multiple sclerosis, psoriasis, inflammatory bowel diseases, and
steroid-resistant asthma (Bettelli et al., 2006; Coccia et al.,
2012; Ivanov et al., 2006; Leonardi et al., 2012; McGeachy and
Cua, 2008; Nylander and Hafler, 2012; Stockinger et al., 2007;
Sundrud et al., 2009).
The RORgt protein belongs to a larger family of receptors
within the nucleus that bind response elements in the genome
to control the expression of multiple genes (Ciofani et al.,
2012). Emerging knowledge of the genome-wide targets of
RORgt and the transcriptional network that controls the differen-
tiation of Th17 cells has uncovered a crucial role for RORgt in the
functions of Th17 cells (Ciofani et al., 2012; Ivanov et al., 2006;
Lee and Cua, 2014; Xiao et al., 2014). Thus, RORgt is an attrac-
tive pharmacological target for the treatment Th17 cell-mediated
immune disorders (Williams, 2013). Indeed, digoxin, SR1001,
TMP778, TMP920, and GSK805 have been identified as small-
molecule compounds that can inhibit the function of RORgt in
various ways (Huh et al., 2011; Lee and Cua, 2014; Solt et al.,
2011; Xiao et al., 2014). Although accumulating evidence sug-
gests the existence of such ligands (Xiao et al., 2014), the nature
of the endogenous ligands of RORgt remains unknown.rs
As an essential player in the adaptive immune system, T cells
have evolved to rapidly respond to invading pathogens. During
the initial priming phase from naive T cells to effector T cell sub-
sets, T cells need to induce reprogramming of their intracellular
metabolism and switch from the catabolic metabolism fulfilling
the minimal biosynthetic requirements for glycolysis to fulfill
the demand for rapid proliferation, growth, and function (Pearce
and Pearce, 2013). Moreover, functionally distinct effector Th
subsets (Th1, Th2, Th17, and Treg cells) have distinct energetic
and biosynthetic pathways, including selective activation of the
mammalian target of rapamycin (mTOR) (MacIver et al., 2013;
Pollizzi and Powell, 2014; Wang and Green, 2012). The role of
the glycolytic pathway in Th cell differentiation has been under
intensive study (Shi et al., 2011). However, it remains largely un-
resolved whether other anabolic processes are involved in Th
cell differentiation and immune responses.
Acetyl-CoA carboxylase 1 (ACC1; encoded by Acaca) is a key
biotinylated enzyme, which catalyzes the ATP-dependent
carboxylation of acetyl-CoA to malonyl-CoA (Wakil et al., 1983)
and regulates cellular fatty acid metabolism. The deletion of
ACC1 in mice resulted in embryonic lethality, indicating that fatty
acid synthesis is essential for embryonic development (Abu-El-
heiga et al., 2005). During the activation of CD8 T cells, the
mTOR-sterol regulatory element-binding proteins (SREBPs)
pathway, together with T cell receptor (TCR) signaling, is
required to induce the genes encoding the fatty acid biosyn-
thesis-related molecules, including Acaca (Kidani et al., 2013).
Moreover, de novo fatty acid biosynthesis is indispensable for
the survival of memory CD8 T cells (O’Sullivan et al., 2014).
These studies indicate that the proper regulation of intracellular
lipid metabolism, including fatty acids and cholesterol, is critical
for appropriate T cell-dependent immune responses. However,
the molecular mechanisms that link functional Th cell differenti-
ation to fatty acid biosynthesis remain poorly defined.
In the present study, we investigated the role of ACC1 on
obesity-induced Th17 cell differentiation and the pathogenicity
of Th17 cells. We found that the expression of fatty acid biosyn-
thesis-related enzymes, including Acaca, was induced by the
intake of a high-fat diet (HFD). Genetic deletion or pharmacolog-
ical inhibition of ACC1 results in impaired Th17 cell differentiation
in both mice and humans, while the overexpression of Acaca
induced Th17 cell differentiation in vivo in mice. ACC1 is found
to control the functions rather than the expression of RORgt in
differentiating Th17 cells, as evidenced by the fact that ACC1
modulates the DNA binding of RORgt to the Il17a gene locus
and the subsequent p300 recruitment. Furthermore, in humans,
obese subjects showed a strong correlation between IL-17A-
producing CD45RO+CD4 T cells and the expression level of
ACACA. Thus, our study points to the existence of a mechanism
by which obesity can exacerbate IL-17-mediated pathology.
RESULTS
An HFD Promotes Th17 Cell Differentiation and Affects
the Expression of Fatty Acid Enzymes in Memory
CD4 T Cells In Vivo
To explore the contribution of obesity to the pathogenicity of
Th17 cells associated with inflammatory diseases, we first inves-Celltigated the proportions of CD44hiCD62Llo memory phenotype
CD4 (MPCD4) T cells in the splenocytes of mice fed an HFD
and a normal diet (ND) for 10 weeks (Figure S1A). A significant
increase in the proportion of MPCD4 T cells (p < 0.01; Mann-
Whitney U test) was observed in HFD mice compared to ND
mice (Figures 1A and S1B). Interestingly, we found increased in-
duction of IL-17A-producing MPCD4 T cells in the HFD mice
compared to ND mice, while no obvious effect was observed
in IFNg-producing MPCD4 T cells (Figures 1B and 1C) (p <
0.01; Mann-Whitney U test).
Next, we examined whether an HFD influenced Th17-depe-
dent pathology in vivo.We used amodel of experimental autoim-
mune encephalitis (EAE) in which Th17 cells are crucial to the
immunopathogenesis (Figure S1A) (Langrish et al., 2005).
Consistent with the increased Th17 cells in HFD mice, an HFD
exacerbated the disease (Figure 1D) (p < 0.01, p < 0.05; Mann-
Whitney U test). The proportion of IL-17A-producing CD44hi
CD4 T cells infiltrating in the CNS was increased in the HFD
group compared to the ND group (Figure 1E).
To determine the potential molecular mechanisms by which
the HFD-induced obesity increased Th17 cell differentiation
in vivo and exacerbated autoimmune encephalitis, we analyzed
the global gene expression profiles of the MPCD4 T cells in HFD
mice. A total of 2,355 probes showed a greater than 2-fold
change (with a false discovery rate < 0.05) between the HFD
and ND groups, including 1,328 upregulated and 1,027 downre-
gulated entries (Figure S1C, upper panel). An analysis of the
gene ontology and canonical pathways showed a significant
enrichment in the lipid metabolic pathways (Figure S1C, lower
panel) (p < 0.01). Among the lipid biosynthetic processes,
increased expression of enzymes in the fatty acid biosynthetic
process appeared to be frequently observed compared to those
involved in the steroid catabolic process (Figures 1F, S1C, and
S1D) (p < 0.05).
Acaca, which encodes acetyl-CoA carboxylase 1 (ACC1) and
is known as a master kinase involved in fatty acid metabolism
(Mao et al., 2006), was one of the top-ranked genes. qPCR anal-
ysis confirmed the upregulation of Acaca and other fatty acid
enzymes in the HFD group (Figure 1G) (p < 0.01; Mann-Whitney
U test).
Inhibition of ACC1 Function Results in Decreased Th17
Cell Differentiation and Ameliorates the Development
of Autoimmune Disease
In order to assess the relevance of ACC1 in controlling Th17 dif-
ferentiation, we investigated the expression of ACC1 and other
fatty acid enzymes in various Th cell subsets, including Th1,
Th2, Th17 and inducible regulatory T (iTreg) cells (Figures S2A
and S2B). Acaca was highly expressed in Th1, Th2 and Th17
cells, but its expression was low in naive CD4 T cells and iTreg
cells (Figure S2C). Interestingly, the generation of IL-17A-pro-
ducing cells was significantly inhibited by 5-(tetradecyloxy)-2-fu-
roic acid (TOFA), a pharmacological inhibitor of ACC1 (Figures
2A and S2D) (p < 0.01; Mann-Whitney U test). We included a ra-
pamycin-treatment group as a positive control for the inhibition
of Th17 cell differentiation (Kurebayashi et al., 2012). TOFA treat-
ment did not affect the viability of Th17 cells (Figure S2E). We de-
tected a substantial decrease in the expression of IL-17A at bothReports 12, 1042–1055, August 11, 2015 ª2015 The Authors 1043
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Figure 1. A High-Fat Diet Promotes Th17 Cell Differentiation and Affects the Expression of Fatty Acid Enzymes inMemory CD4 TCells In Vivo
(A) Expression profiles of CD4, CD62L, and CD44 on splenocytes from mice fed a normal diet (ND) or a high-fat diet (HFD).
(B) Total splenocytes were stimulated with phorbol 12-myristate 13-acetate (PMA) plus ionomycin for four hours. Representative intracellular staining profiles of
IL-17A/IFNg in CD44hiCD4 T cells from ND or HFD mice are shown.
(C) The summary data for the intracellular staining profiles (IL-17A or IFNg) in CD44hiCD4 T cells fromND or HFDmice are shown as the frequencies with standard
deviations. More than five independent experiments were performed with similar results (**p < 0.01, Mann-Whitney U test, n = 7 per group, N.S., not significant).
(D) Disease severity of EAE was monitored and scored daily. Mean clinical scores and standard deviations for the ND and HFD groups over time are presented.
Three independent experiments were performed with similar results (**p < 0.01, *p < 0.05 Mann-Whitney U test, n = 7–10 per group).
(E) Representative intracellular staining profiles of IL-17A/IFNg in CD44hiCD4 T cells in the CNS from MOG/CFA-immunized ND or HFD mice are shown.
(F) A heatmap depicting the differentially expressed genes involved in fatty acid biosynthetic processes in CD44hiMPCD4 T cells from ND and HFD mice.
Highlighted genes in Figure 1F are enzymes that are directly related to the fatty acid biosynthetic process.
(G) qRT-PCR analyses of the relative expression ofAcaca,Scd2,Acsl3, and Pmvk in CD44hiMPCD4 T cells fromND or HFDmice. Relative expression (normalized
to 18S) with SD is shown. Three independent experiments for each group were performed with similar results (**p < 0.01, *p < 0.05).
See also Figure S1.the mRNA and protein levels by the inhibition of ACC1 (Figures
2B and 2C) (p < 0.01; Mann-Whitney U test). We also examined
the effect of a fatty acid synthase inhibitor (C75) and a stearoyl-1044 Cell Reports 12, 1042–1055, August 11, 2015 ª2015 The AuthoCoA desaturase inhibitor (MF-438) on the differentiation of Th17
cells, and both inhibitors suppressed Th17 cell differentiation,
similar to TOFA (Figure S2F) (p < 0.05; Mann-Whitney U test).rs
In contrast, no obvious effect was detected in the generation
of IL-4-producing Th2 cells or Foxp3-expressing iTreg cells in
the induction cultures (Figure S2G). A moderate reduction of
IFNg-producing cells was observed in Th1 cell cultures
(Figure S2G).
We next examined the permissive epigenetic histone modifi-
cations of the Il17a locus and found that TOFA treatment resulted
in a reduction of the permissive marks, specifically the histone 3
lysine 9 and 14 acetylation (Ac-H3K9/14) and histone 3 lysine 4
trimethylation (Me3-H3K4) at the Il17a locus in Th17 cells (Fig-
ures 2D and 2E). To assess the relevance of the inhibition of
ACC1 on the pathogenicity of Th17 cells in vivo, wild-type
C57/BL6 mice were subjected to EAE with or without daily
administration of TOFA (Figure S2H). As shown in Figure 2F,
the administration of TOFA resulted in decreased development
of EAE (p < 0.01, p < 0.05; Mann-Whitney U test). The protection
against the development of EAE by TOFA treatment was associ-
ated with the suppression of IL-17A-producing cells in the CNS
(Figures 2G and 2H) (p < 0.01; Mann-Whitney U test). Further-
more, the administration of TOFA to HFD mice ameliorated
development of EAE accompanied with the decrease of IL-
17A-producing CD4 T cells in the CNS (Figures 2I and 2J). These
results indicate that the inhibition of ACC1 by TOFA treatment in-
hibits Th17 cell differentiation and ameliorates the development
of Th17-related EAE.
ACC1 Controls the Differentiation of Th17 Cells Both
In Vitro and In Vivo
To directly assess the role of ACC1 in Th17 cell differentiation,
we next used mice in which the biotin carboxyl carrier protein
domain in the Acaca gene was conditionally deleted (Mao
et al., 2006) in CD4 T cells by the expression of Cre-recombinase
driven by the Cd4 promoter (herein referred to as Acaca/
mice). Acaca/ mice had normal proportion and numbers of
CD4 and CD8 T cells in the thymus (Figure S3A, upper panel),
whereas the proportion and numbers of CD4 and CD8 T cells
in the spleen was slightly but significantly reduced in the
Acaca/mice compared to the Acaca+/+ or Acaca+/mice (Fig-
ure S3A, lower panel) (p < 0.05; Mann-Whitney U test). The pro-
portion of MPCD4 T cells and naive CD4 T cells was equivalent
among the Acaca+/+, Acaca+/, and Acaca/mice (Figure S3B).
Interestingly, the frequencies of IL-17A-producing MPCD4
T cells were decreased in the Acaca/mice even under homeo-
static conditions (Figure 3A).
Wenext examinedwhether the lossof ACC1couldaffectTh cell
differentiation in vitro. The Th1 and Th2 cell differentiation of
Acaca/ T cells was not impaired, and only a slight upregulation
of Foxp3 was observed in Acaca/ iTreg cells (Figure S3C). In
sharp contrast, a dramatic reduction in the proportion of IL-17A-
producing cells was observed in Acaca/ Th17 cells at both
the early and late phases of differentiation (Figures 3B and S3D)
(p < 0.01; Mann-Whitney U test). Likewise, a significant reduction
in Il17amRNA expression and IL-17A production was detected in
Acaca/ Th17 cells (Figures 3C and3D) (p < 0.01;Mann-Whitney
U test). The expression of Foxp3 was moderately increased in
Acaca/ Th17 cells (day 4 and day 5) (Figures S3E and S3F)
(p < 0.01; Mann-Whitney U test). In agreement with the results
from the pharmacological inhibition of ACC1, the levels of Ac-CellH3K9/14 and Me3-H3K4 at the Il17a locus were decreased in
Acaca/ Th17 cells compared toAcaca+/+ Th17 cells (Figure 3E).
To further investigate the relevance of ACC1 in Th cell function
in vivo, we decided to generate mice with transgenic expression
of Acaca under the control of the T cell-specific Lck distal pro-
moter (herein referred to as Acaca-transgenic mice; Figure S3G).
The proportion of MPCD4 T cells was slightly increased in the
Acaca-transgenic mice (Figure 3F). Overexpression of Acaca in
CD4 T cells in vivo resulted in an increased proportion of IL-
17A-producing MPCD4 T cells, whereas the generation of
IFNg-producing MPCD4 T cells and the expression of Il4 were
equivalent between the Acaca-transgenic and wild-type mice
(Figures 3G, 3H, and S3H). Taken together, these results suggest
that the expression level of Acaca controls Th17 cell differentia-
tion both in vitro and in vivo.
ACC1 Controls the Function, but Not Expression,
of RORgt in Differentiating Th17 Cells
To address the underlying molecular mechanisms by which
ACC1 controls Th17 cell differentiation, we first examined
whether the impairment of ACC1 affected signal transduction
molecules involved in Th17 cell differentiation. STAT3 is a well-
known key signal transducer of Th17 cell differentiation (Durant
et al., 2010). Despite the decreased production of IL-17A by the
inhibition of ACC1 in Th17 cells, the phosphorylation status and
the DNA binding activity of STAT3 to the target sites were not
affected in the presence of TOFA (Figures S4A and S4B). We
next examined the transcription factors involved in Th17 differen-
tiation. Contrary to our expectations, we found no significant dif-
ferences in either the mRNA or protein expression of Th17-
related transcription factors, including Rorc and Rora, in TOFA-
treated Th17 cells or Acaca/ Th17 cells (Figures 4A–4D, S4C,
and S4D). At the cellular level, RORgt protein was equivalent be-
tween control and TOFA-treated Th17 cells (Figure S4E). Consis-
tent with these results, therewere no significant differences in the
level of permissive histone modifications at the Rorc locus be-
tween control and TOFA-treated Th17 cells (Figures S4F and
S4G). In addition, the ectopic expression of constitutively active
formsof STAT3, Irf4, Batf, andRunx1could not restore the reduc-
tion of IL-17A induced by TOFA treatment (Figure S4H).
Although TOFA treatment had no effect on the expression of
RORgt, TOFA-treated Th17 cells had impaired expression of
Il23r, Ltb4r1, andCcr6, whichare known tobeRORgt targets (Fig-
ure 4E) (p < 0.01; Mann-Whitney U test) (Ciofani et al., 2012). The
Acaca/ Th17 cells also showed reduced expression of Il23r,
Ltb4r1, and Ccr6 (Figure 4F) (p < 0.01; Mann-Whitney U test).
Interestingly, TOFAandRORg inhibitor (SR1001) hadnosynergis-
tic inhibitory effect on IL-17A-producing cells (Figure S4I), sug-
gesting that the samemolecule is affectedby these two inhibitors,
which was crucial for Th17 cell differentiation. The inhibition of
ACC1 in Th17 cells resulted in decreased binding of RORgt to
Il17a CNS2a and Il17ap, which are known as enhancer regions
containingputativeRORbindingsitesat the Il17a locus (Figure4G,
upperpanel) (Ciofaniet al., 2012;Wangetal., 2012).Wealso found
a significant reduction in the binding of p300, the core component
of the histone acetyltransferase (HAT) complex (Liu et al., 2008), to
these regions in TOFA-treated Th17 cells (Figure 4G, lower panel).
Moreover, immunofluorescence microscopy revealed that theReports 12, 1042–1055, August 11, 2015 ª2015 The Authors 1045
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Figure 2. Pharmacological Inhibition of ACC1 Reduces Th17 Cell Differentiation In Vitro and the Pathogenicity of Th17 Cells In Vivo
(A) Representative intracellular staining profiles of IL-17A/IFNg in effector Th17 cells treated with DMSO (Control), TOFA (10 mM), or rapamycin (Rap;
5 nM).
(legend continued on next page)
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nuclear localization of RORgt was changed, and the co-localiza-
tion of RORgt and p300 was impaired by the inhibition or deletion
of ACC1 in Th17 cells (Figures 4H and S4J) (p < 0.01; Mann-Whit-
ney U test). The distribution of RORgt in cytosol and nuclear
compartment was similar between control and TOFA-treated
Th17 cells and the level of RORgt protein in the cytosol is relatively
lower than in the nucleus (Figure S4K), indicating that RORgt ex-
ists in the nucleus even in thepresenceof TOFAorAcaca/ cells.
Together, these findings suggest that ACC1 is crucial for the
appropriate functions of RORgt, such as its binding to the Il17a
gene locus and subsequent p300 recruitment.
Extrinsic Fatty Acid Supplementation Restored
Acaca/ Th17 Cell Differentiation through the
Functional Improvement of RORgt
It has been reported that a single amino acid change in the puta-
tive ligandbinding pocket of ROR family completely abrogates its
transactivation activity in cells (Stehlin et al., 2001). Interestingly,
a point mutation in the ligand binding domain of RORgt (A304F)
also impaired the induction of IL-17A-producing cells and the
expression of Il23randCcr6 (FiguresS5A toS5C).Wenext exam-
ined the levels of fatty acids in Th17 cells, and the level of oleic
acid (OA), amonounsaturated fatty acid, was decreased approx-
imately half by treatment of Th17cellswith TOFA (FigureS5D) (p<
0.05;Mann-WhitneyU test). The addition of OA into theAcaca/
Th17 cell culture rescued the generation of IL-17A-producing
cells (Figure 5A). The expression of Il17a was also upregulated
in Acaca/ Th17 cells by the addition of OA (Figure 5B) (p <
0.01; Mann-Whitney U test). At the same time, Acaca/ Th17
cells showed restored expression of Il23r and Ccr6 without any
effect on the expression of Rorc (Figures 5C and S5E) (p < 0.01;
Mann-Whitney U test). AlthoughOA did not significantly enhance
Th17cell differentiation following stimulationwith anoptimal con-
centration of anti-TCRb (10 mM) for Th17 differentiation, the pro-
portion of IL-17A-producing cells was increased by the addition
of extrinsic OA in cultures stimulated with a lower concentration
of anti-TCRb (0.3 mM) (Figure S5F). Furthermore, the decreased
binding of RORgt and p300 to Il17a CNS2a and Il17ap by the in-
hibition of ACC1 was also restored by the addition of OA (Fig-
ure 5D). Immunofluorescence microscopy confirmed that the
co-localization of RORgt and p300 in Acaca/ Th17 cells was
rescued by supplementary OA (Figures 5E and S5G) (p < 0.01;(B) qRT-PCR analysis of Il17a in effector Th17 cells treated with DMSO (control),
(C) ELISA analysis of IL-17A in effector Th17 cells treated with DMSO (control), T
(D) A schematic representation of the mouse Il17a gene locus.
(E) ChIP assays were performed with anti-trimethyl histone H3-K4 and anti-acety
DMSO (control), TOFA (10 mM), rapamycin (Rap.; 5 nM), and effector Th1 cells.
(F) Disease severity of EAE was monitored and scored daily. Mean scores and sta
represented. TOFAwas administrated daily from day 0 to day 20. Three independe
Whitney U test; n = 7–10 per group).
(G) Representative intracellular staining profiles of IL-17A/IFNg in CD44hiCD4 T c
(H) The summary data for the intracellular staining profiles (IL-17A or IFNg) in CD44
standard deviations are shown. Three independent experiments were performed
group).
(I) Mean scores and disease incidence of EAE for the Control and TOFA-adminis
HFD feeding. Two independent experiments were performed with similar results
group two out of six mice died accompanied by severe paralysis (y).
(J) Representative intracellular staining profiles of IL-17A/IFNg in CD44hiCD4 T c
More than three independent experiments were performed with similar results (*
CellMann-Whitney U test). We also assessed the ability of a series
of fatty acids, including saturated and unsaturated fatty acids,
to rescue the differentiation of Acaca/ Th17 cells (Figure S5H).
While petroselinic acid (a monounsaturated fatty acid) partially
rescued the phenotype of Acaca/ Th17 cells, myristic acid
(a saturated fatty acid), dodecanoic acid (a saturated fatty
acid), and docosahexanoic acid (a polyunsaturated fatty acid)
did not. Extrinsic OA partially rescued the differentiation of
Th17 cells treated with SR1001 (Figure S5I). We assessed the ef-
fect of OA on IL-17A production in cells with forced expression of
RORgt and a RORgt (A304F) mutant under Th17 differentiation
conditions. Although extrinsic addition of OA increased the pro-
portion of IL-17A-producing cells in RORgt-infected Th17 cells
in a dose-dependent manner, Th17 cells expressing RORgt
(A304F) mutant did not show a substantial increase in IL-17A-
producing cells by the addition of OA (Figure S5J). Taken
together, these results indicate that metabolic products from
monounsaturated fatty acid biosynthetic process are required
for the function of RORgt to induce Th17 cell differentiation.
Obese Subjects Show Upregulation of ACACA and
Increased Th17 Cells in CD45RO+ Memory CD4 T Cells
Wenext explored the role of ACC1 in human Th17 differentiation.
Consistent with the results in mice, human Th17 cell differentia-
tion was significantly impaired by the inhibition of ACC1 in vitro
(Figures 6A and S6A) (p < 0.01; Mann-Whitney U test). Likewise,
a significant reduction of IL-17A at both the mRNA and protein
levels was detected in human Th17 cells following the inhibition
of ACC1 (Figures 6B and 6C) (p < 0.01; Mann-Whitney U test).
Moreover, small interfering RNA (siRNA)-mediated knockdown
of ACACA resulted in a reduction of IL-17A production by human
Th17 cells (Figures 6D and 6E).
Finally, we sought to gain more insight into the possible path-
ophysiological role of ACC1 in Th17 cells under obese conditions
in humans. To this end, we analyzed the CD45RO+ memory CD4
T cells from the peripheral blood of obese subjects (BMI >
30 kg/m2). The expression levels of TBX21, GATA3, and RORC
were almost equivalent between CD45RO+CD4 T cells from
lean controls and obese subjects (Figure S6C). However, the
expression levels of FOXP3 were significantly lower in the
CD45RO+CD4 T cells from the obese subjects (Figure S6C)
(p < 0.01; Mann-Whitney U test). The expression levels ofTOFA (10 mM), or rapamycin (Rap.; 5 nM).
OFA (10 mM), or rapamycin (Rap.; 5 nM).
l histone H3K9/14 at the Il17a gene locus from effector Th17 cells treated with
ndard deviations for the control and TOFA-administered groups over time are
nt experiments were performedwith similar results (**p < 0.01, *p < 0.05,Mann-
ells from the CNS are shown.
hiCD4 T cells from the Control or TOFA-administered groups. Frequencies with
with similar results (**p < 0.01, *p < 0.05, Mann-Whitney U test; n = 7–10 per
tered HFD groups are shown. TOFA was administrated every other day during
(**p < 0.01, *p < 0.05, Mann-Whitney U test; n = 7–10 per group). In the control
ells from the CNS are shown.
*p < 0.01) for (A)–(E). See also Figure S2.
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Figure 3. The Expression Level of Acaca Controls the Differentiation of IL-17A-Producing Cells
(A) Representative intracellular staining profiles (IL-17A or IFNg) in CD44hiCD4 T cells from Acaca+/+ and Acaca/ mice (n = 3 per group).
(B) Representative intracellular staining profiles of IL-17A/IFNg in Acaca+/+ or Acaca/ effector Th17 cells (day 2 [left panel] and day 5 [right panel]).
(C) qRT-PCR analysis of Il17a in Acaca+/+ or Acaca/ effector Th17 cells (day 2).
(legend continued on next page)
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CD44were equivalent between lean controls and obese subjects
(Figure S6D). Notably, the expression of ACACA and FASN was
increased in CD45RO+memory CD4 T cells from obese subjects
(Figures 6F and S6B) (p < 0.01; Mann-Whitney U test).
Furthermore, a significant increase in IL-17A-producing
CD45RO+ memory CD4 T cells was detected in obese subjects,
whereas there were no significant differences in the frequency of
IFNg-producing cells between the obese subjects and lean con-
trols (Figures 6G and 6H) (p < 0.01; Mann-Whitney U test). The
proportion of CD45RO+CCR6+ CD4 T cells was also significantly
increased in obese subjects (Figures 6I and 6J) (p < 0.01; Mann-
Whitney U test). Remarkably, the proportion of IL-17A-producing
CD45RO+CD4 T cells correlated well with the expression levels
of ACACA in obese subjects (Figure 6K, left panel) (R2 = 0.45,
p = 0.0017; Mann-Whitney U test), whereas there was no corre-
lation between the proportion of IFNg-producing CD45RO+CD4
T cells and the expression level ofACACA (Figure 6K, right panel)
(R2 = 0.08, p = 0.249; Mann-Whitney U test) or between the pro-
portion of IL-17A-producing CD45RO+CD4 T cells and the
expression levels of CD44 (Figure S6E) (R2 = 0.02, p = 0.589;
Mann-Whitney U test). These results suggest that ACC1 plays
a critical role in the obesity-induced Th17 cell differentiation in
human subjects.
DISCUSSION
We herein identified a critical role that ACC1 plays in Th17 cell
differentiation and the pathogenicity of Th17 cells through the
control of the RORgt function under obese circumstances.
High-fat-induced obesity augments Th17 cell differentiation
and the expression of enzymes involved in fatty acid meta-
bolism, including ACC1. Pharmacological inhibition or genetic
deletion of ACC1 resulted in impaired Th17 cell differentiation
in both mice and humans. In contrast, overexpression of Acaca
induced Th17 cells in vivo, leaving the expression of Ifng and Il4
largely unchanged. ACC1 modulated the binding of RORgt to
the Il17a gene and the subsequent p300 recruitment in differen-
tiating Th17 cells. Memory CD4 T cells from peripheral blood
mononuclear cells (PBMCs) of obese subjects showed
increased IL-17A production and ACACA expression. Further-
more, a strong correlation was detected between the propor-
tion of IL-17A-producing cells and the expression level of
ACACA in memory CD4 T cells in obese subjects. Thus, our
findings provide evidence of a mechanism wherein obesity
can exacerbate IL-17-mediated pathology via the induction of
ACC1.
It has been reported that the inhibition of the PI3K-Akt-
mTORC1 pathway inhibits the translocation of RORg from the
cytosol to the nucleus (Kurebayashi et al., 2012). In contrast,(D) ELISA analysis of IL-17A in Acaca+/+ or Acaca/ effector Th17 cells (day 2).
(E) ChIP assays were performed with anti-trimethyl histone H3-K4 and anti-acety
Th17 cells (day 2).
(F) Expression profiles of CD4, CD62L, and CD44 on splenocytes from wild-type
(G) Total splenocytes were stimulatedwith PMA plus ionomycin for 4 hours. Repre
WT or Acaca-Tg mice are shown (n = 3 per group).
(H) qRT-PCR analysis of the relative expression of Il17a and Il4 in CD44hiCD4 T c
Three independent experiments were performed with similar results (**p < 0.01) fo
(F)–(H). See also Figure S3.
Cellour study demonstrated that the deletion or pharmacological in-
hibition of ACC1 changed the nuclear localization of RORgt
without affecting the protein levels of RORgt in the nucleus.
Furthermore, the co-localization of RORgt with p300 was
impaired by the inhibition or deletion of ACC1 in Th17 cells.
These results are in agreement with the data from chromatin
immunoprecipitation (ChIP) analysis using RORgt and p300 an-
tibodies. It has been suggested that an accurate positioning of
regulatory core factors such as TAF3 within the nucleus is corre-
lated with the occupancy at the MyoD promoter in myoblasts
(Yao et al., 2011). In another report, mixed lineage leukemia
(MLL), a transcriptional regulator that maintains transcriptional
activity through the preservation of permissive chromatin,
dynamically changed the localization in the nucleus and the oc-
cupancy at the target genes in a manner dependent on the cell
cycle (Blobel et al., 2009). Therefore, although the position of a
gene in the nucleus does not necessarily determine its activity,
transcription factors need to navigate to the cell nucleus and ac-
cess target genes in order to activate transcription. The current
study demonstrates that the position of a nuclear receptor in
the nucleus and subsequent effects on gene expression could
be modulated by the presence of certain fatty acids.
During differentiation of naive CD4 T cells into distinct effector
Th subsets, activated Th cells undergo an activation process that
induces metabolic reprogramming, switching from catabolic to
anabolic processes such as the glycolytic pathway (MacIver
et al., 2013; Wang and Green, 2012). A number of reports have
suggested that effector Th subsets have metabolically distinct
characteristics (MacIver et al., 2013). In particular, Th1, Th2,
Th17, and Tregs showmarked differences in their metabolic pro-
files (MacIver et al., 2013). Hif-1a is a transcription factor that fa-
cilitates the metabolic switch from oxidative phosphorylation to
aerobic glycolysis and selectively regulates the differentiation
and metabolism of Th17 cells (Dang et al., 2011; Shi et al.,
2011). Hif-1a deficiency suppressed Th17 differentiation and
increased Treg differentiation (Dang et al., 2011; Shi et al.,
2011). Metabolically, the induction of glycolysis by Hif-1a likely
favors Th17 over Treg cells (Shi et al., 2011). Thus, although
the role of the glycolytic pathway in Th cell differentiation is grad-
ually becoming clearer, it remains largely unresolved whether
other anabolic processes are involved in Th cell differentiation
and in immune responses. In the present study, we showed
that direct inhibition of a fatty acid synthesis pathway selectively
blocked Th17 cell differentiation. Consistent with our report,
another recent study suggested that Th17 cell differentiation
and Th17 cell-mediated autoimmune disease were attenuated
by the deletion of Acaca (Berod et al., 2014).
An intriguing finding in the present study is that the expression
of Acaca was increased in the memory CD4 T cells of both HFDl histone H3K9/14 at the Il17a gene locus from Acaca+/+ or Acaca/ effector
(WT) or Acaca-transgenic (Tg) mice.
sentative intracellular staining profiles of IL-17A/IFNg in CD44hiCD4 T cells from
ells from WT or Acaca-Tg mice.
r (A)–(E). Two independent experiments were performed with similar results for
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Figure 5. Extrinsic Fatty Acid Supplementation Restored Acaca/ Th17 Cell Differentiation through the Functional Improvement of RORgt
(A) Representative intracellular staining profiles of IL-17A/IFNg in Acaca+/+ or Acaca/ effector Th17 cells cultured with or without supplemental oleic acid (OA)
(100 mM).
(B) qRT-PCR analysis of the relative expression of Il17a in Acaca+/+ or Acaca/ effector Th17 cells (day 2) cultured with or without OA (100 mM).
(C) qRT-PCR analysis of the relative expression of Il23r, Ltb4r1 or Ccr6 in Acaca+/+ or Acaca/ effector Th17 cells (day 2) cultured with or without OA (100 mM).
(D) ChIP assays were performed with anti-RORg and anti-p300 antibodies at the Il17a CNS2a or Il17ap from effector Th17 cells with DMSO (control) or TOFA
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(E) Immunofluorescent analyses were performed with anti-RORg and anti-p300 antibodies and TOPRO3 using Acaca+/+ or Acaca/ effector Th17 cells in the
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Three independent experiments were performed with similar results (**p < 0.01) for (A)–(C). Two independent experiments were performed with similar results for
(D) and (E). See also Figure S5.mice and obese human subjects compared to ND mice or lean
control subjects. Obesity, an excess of fat accumulation that pre-
sents a health risk, is evoked by nutrient overload and is clinicallyFigure 4. ACC1 Controls the Function, but Not Expression, of RORgt i
(A) qRT-PCR analysis of the relative expression of Rorc or Rora in effector Th17
(B) Protein levels of RORgt and RORa in effector Th17 cells with or without TOFA
(C) qRT-PCR analysis of the relative expression of Rorc or Rora in Acaca+/+ or A
(D) Protein levels of RORgt in Acaca+/+ or Acaca/ effector Th17 cells (day 2).
(E) qRT-PCR analysis of the relative expression of Il23r, Ltb4r1 or Ccr6 in effecto
(F) qRT-PCR analysis of the relative expression of Il23r, Ltb4r1, or Ccr6 in Acaca
(G) ChIP assays were performed with anti-RORg and anti-p300 antibodies at the I
(control) or TOFA (10 mM) and effector Th1 cells.
(H) Immunofluorescent analyses were performed with anti-RORg and anti-p300 a
TOFA (10 mM), Acaca/ effector Th17 cells, and effector Th2 cells.
More than three independent experiments were performed with similar results (**p
results for (H). See also Figure S4.
Celldefined in western countries as a BMI > 30 kg/m2 (Jensen et al.,
2014). In the current study, the BMI of obese subjects ranged
from 30.5 to 50.8 kg/m2, with a median of 41.4 kg/m2, andn Differentiating Th17 Cells
cells treated with DMSO (Control) or TOFA (10 mM).
(10 mM) and effector Th1 cells.
caca/ effector Th17 cells (day 2).
r Th17 cells with DMSO (control) or TOFA (10 mM) treatment.
+/+ or Acaca/ effector Th17 cells (day 2).
l17a CNS2a, Il17ap, Hprtp or Ifngp from effector Th17 cells treated with DMSO
ntibodies and TOPRO3 using effector Th17 cells treated with DMSO (control) or
< 0.01) for (A)–(G). Two independent experiments were performed with similar
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Figure 6. Obese Subjects Have Upregulation of ACACA and Increased Th17 Cells in CD45RO+ Memory CD4 T Cells
(A) Representative intracellular staining profiles of IL-17A/IFNg in human Th17 cells treated with DMSO (control) or TOFA (10 mM).
(B) Results of a qRT-PCR analysis of the IL17A in human Th17 cells treated with DMSO (control) or TOFA (10 mM).
(C) ELISA for IL-17A in human Th17 cells treated with DMSO (control) or TOFA (10 mM).
(D) Representative intracellular staining profiles of IL-17A/IFNg siRNA ACACA siRNA generated are shown.
(legend continued on next page)
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patients with symptomatic or secondary obesity were excluded.
Moreover, the proportion of IL-17A-producing cells show a
strong correlation with the expression levels of ACACA in the
memory CD4 T cells from obese subjects. It remains unknown
which signal(s) induce the expression of Acaca in memory CD4
T cells under obese conditions. Some reports have suggested
that the expansion of IL-17-producing cells under obese condi-
tions is dependent on increased levels of IL-6 or IL-1b in the
spleen and lungs, respectively (Kim et al., 2014; Winer et al.,
2009b), but the connection between these cytokine signals and
the expression of Acaca under obese conditions is still unclear.
The mTOR signaling pathway is another possible candidate for
regulating Acaca expression in memory CD4 T cells under obese
conditions. Indeed, inCD8Tcells or cancer cells, the activation of
themTOR-SREBPpathway plays a crucial role in the induction of
the enzymes involved in fatty acid synthesis, including ACC1 (Du¨-
vel et al., 2010; Kidani et al., 2013). In addition, ribosomal protein
S6kinase1 (S6K1), adownstream target of themTORpathway, is
activated by various nutrients including amino acids and insulin
(Um et al., 2006). If these reports and our present findings are
taken into account, the mTOR-SREBP pathway can be specu-
lated to lead to the induction of Acaca expression as a result of
the overload of nutrients under obese conditions.
In summary, we herein demonstrate that ACC1 regulates the
function of RORgt and consequently determines the pathology
of Th17 cells under obese conditions in both mice and humans.
Thus, ACC1 and fatty acid derivatives could be potential thera-
peutic targets for the treatment of chronic inflammatory diseases
that are associated with sustained Th17 responses in obese
subjects.
EXPERIMENTAL PROCEDURES
Mice
The animals used in this study were backcrossed to BALB/c or C57BL/6 mice
ten times. Acacafl/fl mice (Mao et al., 2006) were crossed with CD4-cre mice
(Jackson Laboratory) and maintained on a C57BL/6 background. Mice with
transgenic expression of Acaca (S79A) under the control of the distal promoter
of the mouse Lck gene were generated on a C57BL/6 background in the
Department of Immunology of Chiba University. The distal promoter was
used to minimize the effects of Acaca overexpression on T cell development
in the thymus. Animals were fed either an ND or an HFD (60 kcal% fat)
(Research Diets). The mice on the HFD received an ND for the first 6 weeks
and then received an HFD for the following 10 weeks. All mice were used
when they were 6–8 weeks old, except for the HFDmice, and were maintained
under SPF conditions. C57BL/6 mice and BALB/c mice were purchased from(E) Results of qRT-PCR analysis of IL17A and ACACA in siRNA ACACA siRNA g
(F) qRT-PCR analysis of the relative expression of ACACA in human CD45RO+CD
Relative expression (normalized to 18S) with the standard deviation is shown. M
(G) Total PBMCs were stimulated with PMA plus ionomycin for 4 hours. Intracell
controls (lean) or obese subjects (obese) are shown. Representative results with
(H) All data for the intracellular staining profiles (IL-17A or IFNg) in human CD45RO
are shown (**p < 0.01, Mann-Whitney U test; N.S., not significant).
(I) Representative expression profiles of CD45RO and CCR6 on human CD4 T ce
(J) All data for the cell surface profiles (CCR6+CD45RO+) in CD4 T cells from le
deviations are shown (**p < 0.01, Mann-Whitney U test; N.S., not significant).
(K) Correlation of the frequencies of IL-17A+ cells or IFNg+ cells withACACA expre
of the correlation index (R2) is shown for each correlation (R2 = 0.45 for IL-17A+ v
Three independent experiments were performed with similar results (**p < 0.01) fo
(D) and (E). See also Figure S6.
CellClea. The animal care was conducted in accordance with the guidelines of
Chiba University.
Mouse T Cell Cultures
Naive (CD44loCD62Lhi) CD4 T cells were purified from the spleens of mice us-
ing a FACS Aria cell sorter (BD Biosciences). In some experiments, memory
phenotype CD44hiCD62Llo CD4 T cells were also sorted as described above.
Naive CD4 T cells were plated onto 24-well tissue culture plates (Costar) pre-
coated with 10 mg/ml anti-TCRb antibody (clone H57-597) with 1 mg/ml anti-
CD28 antibody (clone 37.51, BioLegend). The Th1 cell cultures contained
IL-2 (15 ng/ml), recombinant mouse IL-12 (10 ng/ml) (Wako) and anti-IL-4 anti-
body (BD Biosciences). The Th2 cell cultures contained IL-2 (15 ng/ml), recom-
binant mouse IL-4 (100 ng/ml) (Peprotech), and anti-IFNg antibody (Bio-
Legend). Non-polarized Th cell cultures contained IL-2 (15 ng/ml), anti-IL-4
antibody, and anti-IFNg antibody. The Th17 cell cultures contained anti-IL-2
(BD biosciences), recombinant mouse IL-6 (Peprotech) (10 ng/ml), recombi-
nant human TGFb (1 ng/ml) (Peprotech), recombinant mouse IL-1b
(10 ng/ml) (Peprotech), recombinant mouse IL-23 (10 ng/ml) (R&D Systems),
anti-IL-4 antibody, and anti-IFNg antibody. The iTreg cell cultures contained
IL-2 (15 ng/ml), anti-IFNg antibody (clone R4-6A2), anti-IL-4 antibody (clone
11B11), and recombinant human TGFb (10 ng/ml) (Peprotech). Oleic acid
(Sigma-Aldrich) was dissolved in DMSO to a final concentration of 100 mM
and was complexed to BSA. Naive CD4 T cells were cultured under Th17 con-
ditions in the presence of the indicated concentrations of oleic acid.
Human T Cell Cultures
Human CD4 T cells were collected by RosetteSep (STEMCELL Technologies)
and a Ficoll gradient. For human naive CD4 T cells, CD45RA+CD45RO cells
were collected, and for memory CD4 T cells, the CD45RO+ fraction was sorted
using a FACS Aria cell sorter (BD Biosciences). Human naive CD4 T cells were
plated onto 48-well tissue culture plates (Costar) pre-coated with 1 mg/ml anti-
CD3 with anti-CD28 antibody. The Th17 cell cultures contained anti-IL-2 (BD
biosciences), recombinant human IL-6 (10 ng/ml) (HumanZyme), recombinant
human TGFb (1 ng/ml) (HumanZyme), recombinant human IL-1b (10 ng/ml)
(HumanZyme), recombinant human IL-23 (10 ng/ml) (HumanZyme), anti-IL-4
antibody, and anti-IFNg antibody.
Immunofluorescent Staining and Confocal Microscopy
The cells were fixed with 4.0% formaldehyde for 10 min, permeabilized with
0.1% Triton X-100 in PBS for 10 min on ice, blocked with 3% BSA in PBS
for 15 min, and stained with the indicated antibodies for 30 min in the dark.
Alexa 488 and Alexa Fluor 555 goat anti-rat/rabbit IgG F(ab)02 fragments
were used as secondary antibodies. Images were obtained using a confocal
laser microscope (LSM710; Carl Zeiss). For statistical analysis, 100 RORgt+
cells were examined independently in each sample and the frequencies of
the cells merged with p300 were calculated.
Patients
Obese subjects were recruited fromChiba University Hospital. All patients met
the criteria for primary obesity defined as a BMI > 30 kg/m2. The male:femaleenerated human Th17 cells.
4 T cells from lean (n = 18) controls or obese subjects (n = 25) was performed.
ean values and SD are shown (**p < 0.01, Mann-Whitney U test).
ular staining profiles of IL-17A/IFNg in human CD45RO+CD4 T cells from lean
the frequencies in each quadrant are shown.
+CD4 T cells from lean (n = 18) or obese subjects (n = 20). Frequencies and SDs
lls in the peripheral blood from lean or obese subjects are shown.
an (n = 19) or obese subjects (n = 25) are shown. Frequencies and standard
ssion in humanCD45RO+CD4 T cells from obese subjects is shown. The square
ersus ACACA, p = 0.0017 and R2 = 0.08 for IFNg+ versus ACACA, p = 0.249).
r (A)–(C). Two independent experiments were performed with similar results for
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ratio of obese subjects was 5:20. The age of obese subjects ranged from 27 to
66 years, with a median of 48.2 years. The BMI of obese subjects ranged from
30.5 to 50.8 kg/m2, with a median of 41.4 kg/m2, and patients with symptom-
atic or secondary obesity were excluded. The male:female ratio of lean
controls was 3:15. The age of lean controls ranged from 22 to 50 years, with
a median of 34.7 years. The BMI of lean controls ranged from 18.4 to
25.2 kg/m2, with a median of 21.0 kg/m2. All patients signed informed consent
forms, and the study was approved by the ethics committee of the Chiba Uni-
versity Graduate School of Medicine and each participating hospital (#1583).
Statistical Analysis
The data were analyzed with the GraphPad Prism software program (version
6). Comparisons of the two groups were performed using a non-parametric
Mann-Whitney U test. Differences with values of p < 0.05 or p < 0.01 were
considered to be significant.
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